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Abstract
Toxicogenomics is a rapidly developing discipline focused on the elucidation of the molecular and cellular effects
of chemicals on biological systems. As a collaborative study group of Toxicogenomics/JEMS·MMS, we conducted
studies on hepatocarcinogens in rodent liver in which 100 candidate marker genes were selected to discriminate
genotoxic hepatocarcinogens from non-genotoxic hepatocarcinogens. Differential gene expression induced by 13
chemicals were examined using DNA microarray and quantitative real-time PCR (qPCR), including eight genotoxic
hepatocarcinogens [o-aminoazotoluene, chrysene, dibenzo[a,l]pyrene, diethylnitrosamine (DEN), 7,12-
dimethylbenz[a]anthracene, dimethylnitrosamine, dipropylnitrosamine and ethylnitrosourea (ENU)], four non-
genotoxic hepatocarcinogens [carbon tetrachloride, di(2-ethylhexyl)phthalate (DEHP), phenobarbital and
trichloroethylene] and a non-genotoxic non-hepatocarcinogen [ethanol]. Using qPCR, 30 key genes were
extracted from mouse livers at 4 h and 28 days following dose-dependent gene expression alteration induced
by DEN and ENU: the most significant changes in gene expression were observed at 4 h. Next, we selected
key point times at 4 and 48 h from changes in time-dependent gene expression during the acute phase
following administration of chrysene by qPCR. We successfully showed discrimination of eight genotoxic
hepatocarcinogens [2-acetylaminofluorene, 2,4-diaminotoluene, diisopropanolnitrosamine, 4-dimethylaminoazobenzene,
4-(methylnitsosamino)-1-(3-pyridyl)-1-butanone, N-nitrosomorpholine, quinoline and urethane] from four non-genotoxic
hepatocarcinogens [1,4-dichlorobenzene, dichlorodiphenyltrichloroethane, DEHP and furan] using qPCR and principal
component analysis. Additionally, we successfully identified two rat genotoxic hepatocarcinogens [DEN and 2,6-
dinitrotoluene] from a nongenotoxic-hepatocarcinogen [DEHP] and a non-genotoxic non-hepatocarcinogen [phenacetin]
at 4 and 48 h. The subsequent gene pathway analysis by Ingenuity Pathway Analysis extracted the DNA damage
response, resulting from the signal transduction of a p53-class mediator leading to the induction of apoptosis. The
present review of these studies suggests that application of principal component analysis on the gene expression profile
in rodent liver during the acute phase is useful to predict genotoxic hepatocarcinogens in comparison to non-genotoxic
hepatocarcinogens and/or non-carcinogenic hepatotoxins.
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Background
Recently, a radical overhaul of toxicological test proto-
cols has been proposed [1–4]. For example, Hartung
wrote that after several productive decades, in which a
patchwork of testing approaches was formed, fewer and
fewer of the latest scientific development were incorpo-
rated [1]. Caiment et al. [4] wrote that one of the main
challenges of toxicology is the accurate prediction of
compound carcinogenicity. The default test model for
assessing chemical carcinogenicity, the 2-year rodent
cancer bioassay, is currently criticized because of its
limited specificity. With increased societal attention
and new legislation against animal testing, toxicologists
urgently need an alternative to the current rodent bio-
assays for chemical cancer risk assessment. In the be-
ginning of the 21st century, toxicogenomics approaches
proposed to use global high-throughput technologies
(transcriptomics) to study the toxic effect of com-
pounds on a biological system.
For risk assessment purposes, there is a general agree-
ment that the chemicals acting through genotoxic and
non-genotoxic mechanisms of carcinogenesis should be
distinguished [5]. Mathijs et al. hypothesized that geno-
toxic and non-genotoxic carcinogens induce distinct
gene expression profiles, which may therefore be used to
classify the mechanisms of compounds as either geno-
toxic carcinogens or non-genotoxic carcinogens [6].
DNA microarray, which is a powerful technology for
characterizing gene expression on a genome-wide scale
[7], developed toxicogenomics. Quantitative real-time
PCR (qPCR) is the field standard for measuring gene
expression and is the most sensitive technique for the
detection and quantification of mRNA target [8].
In the present study, we summarize our collabora-
tive studies in toxicogenomics. We first selected about
100 candidate marker genes to discriminate mouse
genotoxic hepatocarcinogens from non-genotoxic
hepatocarcinogens by DNA microarrays, which were
next quantified by qPCR [9]. We extracted about 30
key genes from dose responses in gene expression
[10] and selected key point times at the beginning
and end of the acute phase (4 and 48 h) [11]. We
successfully showed the discrimination of genotoxic
and non-genotoxic hepatocarcinogens in mouse liver
[12] and rat liver [13] by qPCR and the application of
principal component analysis (PCA) at 4 and 48 h
after administration of hepatocarcinogens. The subse-
quent gene pathway analysis by Ingenuity Pathway
Analysis extracted the DNA damage response, result-
ing from signal transduction by a p53-class mediator
leading to the induction of apoptosis. Application of
PCA was useful to discriminate genotoxic hepatocar-
cinogens from non-genotoxic and/or non-genotoxic
non-hepatocarcinogens on rodent liver.
Selection of genes by DNA microarray and quantified by
real-time PCR
In our preliminary study, we examined differential
gene expression of 13 chemicals including eight geno-
toxic hepatocarcinogens [o-aminoazotoluene, chrysene,
dibenzo[a,l]pyrene, DEN, 7,12-dimethylbenz[a]anthra-
cene, dimethylnitrosamine, dipropylnitrosamine, and
ENU], four non-genotoxic hepatocarcinogens [carbon
tetrachloride, DEHP, phenobarbital, and trichloroethyl-
ene], and a non-genotoxic non-hepatocarcinogen (for
mouse) [ethanol] using DNA microarray (Affymetrix
GeneChip Mu74A V2 and in-house microarray) in
mouse liver at 4 h and up to 28 days following a
single intraperitoneal administration to groups of five
9-week-old B6C3F1 male mice. The cDNA was pre-
pared with total RNA combined from pooled livers.
After preliminary DNA microarray data were gener-
ated, results were confirmed by qPCR. We identified
about 100 candidate genes to discriminate the geno-
toxic hepatocarcinogens from the non-genotoxic
hepatocarcinogens. The results were published in part
[9] and registered to the GEO database (GEO acces-
sion GSE33248). The changes in gene expression at
4 h were much greater than at 20 h, 14 days, and
28 days. We used qPCR in continual studies.
Dose-dependent alterations in gene expression at 4 h
and 28 days
We examined the dose-dependent gene expression
changes in candidate marker genes from our previ-
ous studies in mouse liver treated with two N-
nitroso genotoxic hepatocarcinogens to extract key
genes, and reported the results of 51 genes deter-
mined by qPCR [10]. DEN at doses of 3, 9, 27, and
80 mg/kg body weight (bw) (LD50: 200 mg/kg bw,
oral) or ENU at doses of 6, 17, 50, and 150 mg/kg bw
(LD50: 200 mg/kg bw, intraperitoneally) were administered
to groups of five 9-week-old B6C3F1 male mice, and the
livers were dissected after 4 h and 28 days. Control mice
received sterile water. The cDNA was prepared with total
RNA from pooled livers and qPCR relative quantitative
values were normalized using the Gapdh housekeeping
gene. A total of 32 genes exhibited a dose response either
via increased or decreased expression at least once at 4 or
48 h by DEN or ENU. At 4 h, as shown in Fig. 1 (Fig. 2 in
[10]), 26 genes showed an obvious dose-dependent in-
crease in gene expression by DEN [Aen (Isg20l1), Bax,
Btg2, Ccng1, Ccng2, Cdkn1a, Cyp4a10, Cyp21a1, Fos,
Gadd45b, Gdf15, Hmox1, Hspb1, Hspb2, Igfbp1, Jun,
Mbd1, Mdm2, Myc, Net1, Plk2, Pmm1, Ppp1r3c, Rad52,
Rcan1, and Tubb4b (Tubb2c)] from over 2-fold to 64-fold.
Two genes [Cyp1a2 and Glul] showed a dose-dependent
decrease in the DEN-treated sample at 4 h. ENU exhibited
similar results except for a few genes (Fabp5 and
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Hist1h1c), although the increase in gene expression to
ENU was generally weaker than to DEN. At 28 days,
DEN induced a dose-dependent increase, between 2-
and 4-fold, in four genes [Btg2, Cdkn1a, Cyp21a1,
and Gdf15], and a dose-dependent decrease in Igfbp1
by less than 0.3-fold. ENU exhibited similar results
except for the genes Casp1, Gstk1, Hspab1, and Ung.
Only Gdf15 displayed a dose-dependent increase in
expression on day 28 for both carcinogens. In
addition, gene networks were analyzed using Ingenu-
ity Pathway Analysis (IPA, http://www.ingenuity.com/
products/ipa), a web-based software application for
the analysis, integration, and interpretation of data
derived from ‘omics experiments’ such as our qPCR
data. Five gene networks were extracted by IPA: Net-
work 1 consisted of genes related to cancer and cell-
cycle arrest, such as Bax, Btg2, Ccng1, Cdkn1a,
Gadd45b, Gdf15, Hspb1, Hspb2, Mdm2, Plk2, and
Pmm1; Network 2 comprised cell cycle, DNA replica-
tion and recombination, repair, and cell death genes,
such as Ccng2, Cyp1a2, Cyp4a10, Cyp21a1, Gdf15,
Ppp1r3c, Rcan1, and Tubb4b (Tubb2c).
Fig. 1 Cluster analysis of gene expression after DEN treatment. The expression of 50 genes was clustered by hierarchical clustering after DEN
treatment. Results of 4 h and 28 days were analyzed separately. The color displays show the log2 (expression ratio) as (1) red when the treatment
sample is up-regulated relative to the control (vehicle) sample, (2) blue when the treatment sample is down-regulated relative to the control sample
and (3) white when the log2 (expression ratio) is close to zero. Fig. 2 in [10]
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Time-course changes in gene expression at the acute stage
within 48 h
We previously noticed that changes in gene expression
were greater at 4 h, while reports on changes in the gene
expression profile in rodent liver at the acute stage in
the first 48 h after administration of a hepatocarcinogen
were limited. We therefore selected key point times at 4
and 48 h from changes in time-dependent gene expres-
sion in mouse liver during the acute phase between 4
and 48 h after administration of chrysene, a polycyclic
aromatic hydrocarbon (PAH) and genotoxic hepatocarci-
nogen, as determined by qPCR [11]. Chrysene (100 mg/
kg bw) was injected intraperitoneally into groups of
three 9-week-old B6C3F1 male mice, and 4, 16, 20, 24,
and 48 h later, livers were dissected and processed for
gene expression. The cDNA was prepared with total
RNA from each individual liver, and the amount of each
gene was quantified by qPCR. We reported the results
from 50 genes, 35 of which exhibited statistically signifi-
cant increases at least once within 48 h after exposure to
chrysene (Table 1). Fifteen genes [Bhlhe40, Btg2, Casp4,
Ccng2, Cdkn1a, Crp, Cyp1a1, Cyp1a2, Fkbp5, Gadd45b,
Gadd45g, Hmox1, Igfbp1, Lcn2, and Ly6a] at 4 h, six
genes at 16 h, seven genes at 20 h, seven genes at 24 h,
and 10 genes [Bhlhe40, Ccnf, Cyp1a1, Cyp1a2, Ephx1,
Hhex, Hmox1, Rcan1, Tubb2a, and Tubb4b] at 48 h
showed statistically significant increases of more than 2-
fold. No significant decreases in gene expression were
observed in this study. IPA at 4 h revealed that 7 genes
[Btg2, Ccng2, Cdkn1a, Gadd45b, Gadd45g, Phlda3, and
Mdm2] of 18 genes, which showed statistically signifi-
cant increases, were associated with cancer, cell cycle,
cell death and survival, and cellular growth and prolifer-
ation. The expression-increased genes from 16 to 48 h
were associated with various biological processes includ-
ing cancer. Cyp1a1 and Cyp1a2 showed remarkably con-
sistent increases in gene expression during 4–48 h.
These two genes are associated with toxin metabolism,
the oxidation-reduction process, and the induction by
carcinogenic polycyclic aromatic hydrocarbons as re-
ported previously [14]. We noticed that the greatest
characteristic differences between 4 and 48 h were with
11 genes [Ly6a, Gadd45g, Igfbp1, Lcn2, Casp4, Cdkn1a,
Btg2, Ccng2, Fkbp5, Crp, and Gadd45b], which differen-
tially exhibited a statistically significant increase more
than 2-fold at 4 h, and six genes [Tubb2a, Ephx1, Hhex,
Ccnf, Rcan1, and Tubb4b] differentially showed a statis-
tically significant increase more than 2-fold at 48 h.
Discrimination of genotoxic and non-genotoxic
hepatocarcinogens at 4 and 48 h in mouse liver
We next successfully showed the discrimination of
eight genotoxic hepatocarcinogens from four non-geno-
toxic hepatocarcinogens at 4 and 48 h in mouse liver by
qPCR and statistical analysis using the Dunnett’s test,
Welch’s t-test, and PCA [12]. Eight genotoxic hepato-
carcinogens, 2-acetylaminofuluorene (300 mg/kg bw),
2,4-diaminotoluene (200 mg/kg bw), diisopropanolni-
trosamine (500 mg/kg bw), 4-dimethylaminoazobenzene
(100 mg/kg bw), 4-(methylnitrosamino)-1-(3-pyridyl)-1-
butanone (250 mg/kg bw), N-nitrosomorpholine (32 mg/
kg bw), quinoline (100 mg/kg bw), and urethane
(1000 mg/kg bw) and four non-genotoxic hepatocarcino-
gens, 1,4-dichlorobenzene (1000 mg/kg bw), dichlorodi-
phenyltrichloroethane (50 mg/kg bw), DEHP (2000 mg/kg
bw), and furan (30 mg/kg bw) were injected intraperitone-
ally into groups of five 9-week-old B6C3F1 males, livers
were collected at 4 and 48 h later, and processed for gene
expression. The cDNA was prepared with total RNA from
each individual liver, and the gene expression was quanti-
fied by qPCR. Control mice received a solvent diluent, ei-
ther saline or olive oil. We reported the results from 35
genes: 34 genes [Aen, Bax, Bhlhe40, Btg2, Ccnf, Ccng1,
Cdkn1a, Cyp1a2, Ddit4, Ddit4l, Egfr, Ephx1, Gadd45b,
Gdf15, HistH1, Hmox1, Hspb1, Igfbp1, Jun, Lrp1, Ly6a,
Mbd1, Mdm2, Phlda3, Plk2, Pml, Pmm1, Ppp1r3c, Psma3,
Rad52, Rcan1, St3gal5, Trp53, and Tubb4b (Tubb2c)]
showed statistically significant changes in their gene ex-
pression, at least once at 4 h and/or 48 h, as computed by
the Dunnett’s test using the Gapdh gene to normalize the
data. The statistical significance between the genotoxic
and non-genotoxic hepatocarcinogens for each gene was
assessed by the Welch’s test at 4 and 48 h after chemical
administration. Different sets of 17 genes [Aen, Bax, Btg2,
Ccng1, Cdkn1a, Egfr, Gdf15, Hist1h1c, Jun, Lrp1, Mbd1,
Mdm2, Phlda3, Plk2, Pml, Ppp1r3c, and Tubb4b
(Tubb2c)] at 4 h, and 19 genes [Aen, Bax, Btg2, Ccnf,
Ccng1, Cdkn1a, Ddit4l, Ephx1, Gadd45b, Gdf15, Lrp1,
Ly6a, Mdm2, Phlda3, Plk2, Pmm1, Ppp1r3c, St3gal5, and
Tubb4b (Tubb2c)] at 48 h showed a statistical significance
between the genotoxic and non-genotoxic hepatocarcino-
gens, as analyzed by the Welch’s test.
Fourteen genes [Aen, Bax, Cdkn1a, Mdmd2, Btg2,
Ccng1, Ddit4, Gdf15, Hist1h1c, Hmox1, Hspb1, Phlda3,
Plk2, and Pml] identified in this study have been re-
ported to be directly associated with Trp53. Among
these, 11 genes [Aen, Bax, Btg2, Ccng1, Cdkn1a, Gdf15,
Hist1h1c, Mdm2, Phlda3, Plk2, and Pml] showed a
statistical significance between the genotoxic and non-
genotoxic hepatocarcinogens analyzed by the Welch’s t-
test at 4 and/or 48 h. Seven major biological processes
were extracted from the Gene Ontology analysis (Gene
Ontology Consortium: geneontology.org), which were
apoptosis, cell cycle and proliferation, DNA damage and
repair, oncogenes, and tumor suppression. IPA sug-
gested the DNA damage response pathway resulting
from signal transduction by a p53-class mediator was
likely leading to the induction of apoptosis. Although
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Table 1 Gene expression ratio (Exp/Cont) and Welch’s t-test after chrysene administration
The total RNA was extracted from the individual liver and used to prepare the cDNA. The expression of the 37 genes was quantified by qPCR, and the gene
expression ratio (exp/cont) of each gene was calculated. The results were analyzed by Welch’s t-test (boldface with ** indicates significant at P < 0.01; boldface
with * indicates significant at P < 0.05). The clusters in Table 1 were sorted through unsupervised hierarchical clustering. The dark pink color shows the values that
are higher than 2, and the light pink color shows the values that are higher than 1.5. The table is simplified from Table 3 in [11]
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we did not observe a significant increase more than
2-fold in Trp53 expression, it was reported that after ex-
posure to DNA-damaging agents, and other stress stimuli,
p53 protein was stabilized and activated by a series of
post-translational modifications that freed it from MDM2,
a ubiquitination ligase responsible for its ubiquitination
prior to proteasome degradation [15].
Discrimination of the gene expression profile between
the genotoxic and nongenotoxic hepatocarcinogens was
achieved by statistical analysis using PCA.
Useful application of PCA on gene expression profile to
discriminate genotoxic and non-genotoxic
hepatocarcinogens
We performed a statistical analysis using a logarithmic
(log2) transformation of the data to stabilize the vari-
ance. PCA is a classic statistical procedure and is re-
cently increasingly applied to biological data. PCA
involves a mathematical procedure that transforms a
number of possibly correlated variables into a smaller
number of uncorrelated variables called “principal com-
ponents”. The first principal component (PC1) accounts
for as much of the variability in the data as possible, and
each succeeding component accounts for as much as of
the remaining variability as possible.
The mathematical formula of PC1 (z1) for 4 h is
presented as the following:
z1 4hð Þ ¼ a11x1 þ a12x2 þ ‐‐‐‐ þ a1pxp;
where a1p is the eigenvector and x is the canonical loga-
rithmic (log2)-transformed gene ratios (exp/cont). PCA
was performed using the PCA programs in Gene-
SpringGX11.0.1 (Agilent Technologies, Santa Clara, CA,
USA). Initially, PCA was applied to all 34 logarithmic
(log2) transformed ratios (exp/cont), and subsequently
tried with various candidate gene sets until the optimal
discrimination was observed. The candidate genes were
selected primarily using the Welch’s t-test from the re-
sults at 4 h, 48 h, and a combination of both times [12].
PCA can be also performed using a free software R
(https://cloud.r-project.org/).
We selected specific genes to obtain an optimal separ-
ation between genotoxic hepatocarcinogens and non-
genotoxic hepatocarcinogens using PCA. Seven genes
[Btg2, Ccnf, Ccng1, Lrp1, Mbd1, Phlda3, and Tubb4b
(Tubb2c)] were used for PCA at 4 h, 12 genes [Aen, Bax,
Btg2, Ccnf, Ccng1, Cdkn1a, Gdf15, Lrp1, Mbd1, Phlda3,
Plk2, and Tubb4b] at 48 h, and a combination of both
time points (Fig. 2).
Fig. 2 Principal component analysis (PCA) of the gene expression levels between genotoxic and non-genotoxic hepatocarcinogens in mouse liver as
quantified by qPCR. The mean values of triplicate qPCR assays for each sample were analyzed statistically using the PCA program in GeneSpringGX11.0.1.
The results of the PCA are shown as the two-dimensional contribution scores for component numbers 1 and 2 (PC1 and PC2). The contribution scores
were produced by conversion from each eigenvector value, at 4 h with 7 genes (a) and at 48 h (b) and a combination of both time points (c) with 12
genes described in the text. Genotoxic hepatocarcinogens, red colored, DIPN: diisopropanolnitrosamine, NNK: 4-(methylnitrosamino)-1-(3-pyridyl)-1-
butanone, NNM: N-nitrosomorpholine, QN: quinoline, DAT: 2,4-diaminotoluene, DAB: 4-domethylaninoazobenzene, 2AAF: 2-acetylaminofluorene, URE:
urethane) and non-genotoxic hepatocarcinogens (blue-colored, FUR: furan, DDT: dichlorodiphenyltrichloroethane, DEHP: di(2-ethylhezyl)phthalate,
DCB: 1,4-dichlorobenzene). Dashed line is added between genotoxic and non-genotoxic hepatocarcinogens. Fig. 2 in [13]
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Differentiation between genotoxic and non-genotoxic
hepatocarcinogens at 4 and 48 h in rat liver
Finally, we examined hepatocarcinogens in rat liver, and
showed successful differentiation of two genotoxic
hepatocarcinogens [DEN and 2,6-dinitrotoluene] from a
nongenotoxic-hepatocarcinogen [DEHP], and a non-
genotoxic non-hepatocarcinogen [phenacetin] at 4 and
48 h by qPCR and PCA [13]. Candidate genes were se-
lected from the data generated in mice. Two genotoxic
hepatocarcinogens: DEN (12.5, 25, and 50 mg/kg bw)
and 2,6-dinitrotoluene (125 and 250 mg/kb bw), a non-
genotoxic hepatocarcinogen: DEHP (1000 and 2000 mg/
kg bw), and a non-genotoxic non-hepatocarcinogen:
phenacetin (500 and 1000 mg/kg bw) were examined in
liver samples from groups of four 4-week-old F344 male
mice at 4 and 48 h after a single oral administration of a
chemical. Control rats received a solvent of sterile water
or olive oil. The cDNA was prepared with total RNA
from each individual liver. We reported results from 33
genes: 32 genes [Aen, Bax, Btg2, Ccnf, Ccng1, Cdkn1a,
Cyp21a1, Cyp4a1, Ddit4l, Egfr, Ephx1, Gadd45b,
Gadd45g, Gdf15, Hhex, Hmox1, Hspb1, Igfbp1, Jun, Lpp,
Ly6al, Mdm2, Myc, Net1, Phlda3, Plk2, Pml, Pmm1,
Rcan1, Tnf, Tp53, and Tubb4b (Tubb2c)] exhibited sta-
tistically significant changes in expression according to
statistical analysis using the Williams’ test and the
Dunnett’s test; and a normalized gene, Gapdh. The
changes appeared to be greater at 4 h than at 48 h.
Statistical analysis via PCA successfully differentiated the
genotoxic hepatocarcinogens from the nongenotoxic
hepatocarcinogen and non-genotoxic non-hepatocarcinogen
at 4 h based on 16 genes [Ccnf, Ccng1, Cy4a10, Ddit4l, Egfr,
Gadd45g, Gdf15, Hspb1, Igfbp1, Jun, Myc, Net1, Phlda3,
Pml, Rcan1, and Tubb4b (Tubb2c)], and 48 h based on 10
genes [Aen, Ccng1, Cdkn1a, Cyp21a1, Cyp4a10, Gdf15,
Igfbp1, Mdm2, Phlda3, and Pmm1] (Fig. 3). Eight major
biological processes were extracted from a Gene Ontology
analysis: apoptosis, cell cycle and proliferation, DNA dam-
age and repair, oxidative stress, oncogenes, and tumor
suppression. IPA suggested the DNA damage response,
which signals through a Tp53-mediated pathway and leads
to the induction of apoptosis: 24 genes are associated with
Tp53 directly or indirectly (Fig. 4). This study showed that
mouse candidate marker genes are applicable to rats for
the differentiation of the genotoxic hepatocarcinogens
from the non-genotoxic hepatocarcinogens examined in
this study.
Discussion
Recently, a new toxicogenomics tool for hepatocarcino-
genicity evaluation of drug candidates in rodents (mainly
rats) was reported: ToxDBScan (http://www.ra.cs.uni-
tuebingen.de/software/ToxDBScan/) [16], which is a web
tool offering a quick and easy similarity screening of
new drug candidates against two large-scale public data-
bases, which contain expression profiles for substances
with known carcinogenic profiles: TG-GATEs (http://
toxico.nibiohn.go.jp/english/) [17] and DrugMatrix
(https://ntp.niehs.nih.gov/drugmatrix/) [18]. TG-GATEs
contains DNA microarray data on 170 chemicals,
Fig. 3 PCA of the gene expression levels under treatment with 3 types of carcinogens in rat liver as quantified by qPCR. Genotoxic hepatocarcinogens
(red-colored, DENL: DEN low dose, DEN-M: DEN middle dose, DEN-H: DEN high dose, DNT-L: DNT low dose, DNT-H: DNT high dose), a non-genotoxic
carcinogen (brown-colored, DEHP-L: DEHP low dose, DEHP-H: DEHP high dose) and a non-genotoxic non-hepatocarcinogen (blue-colored, PNT-L: PNT low
dose, PNT-H: PNT high dose). The mean values of triplicate qPCR assays for each sample were analyzed statistically using the PCA program
in GeneSpringGX11.0.1. The results of the PCA are shown as the two-dimensional contribution scores for component numbers 1 and 2
(PC1 and PC2). The contribution scores were produced by conversion from each eigenvector value, at 4 h with 16 genes and at 48 h
with 10 genes described in the text. PCA successfully differentiated the genotoxic hepatocarcinogen (red circle) from the non-genotoxic
hepatocarcinogen (brown circle) and non-genotoxic and non-hepatocarcinogen (blue circle) with PC1 and PC2. Fig. 2 in [15]
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primarily medicinal compounds. DrugMatrix contains
toxicogenomic profiles (DNA microarray data) for 638
different compounds. These compounds include US
Food and Drug Administration-approved drugs, drugs ap-
proved in Europe and Japan, withdrawn drugs, drugs in
preclinical and clinical studies, biochemical standards, and
industrial and environmental toxicants. Although these
large databases based on DNA microarrays were prepared,
the number of published papers on toxicogenomics by
DNA microarrays and qPCR in rodent liver or liver cells
was not as expected.
Since its first application to toxicogenomics in 2003,
PCA is a classic statistical technique that is recently in-
creasingly applied to biological data. Previously, we suc-
cessfully applied PCA to human lung cancer cell lines
[19, 20]. Successful discrimination was performed in
some toxicogenomics studies, such as hepatocarcinogens
against non-carcinogens in rat liver [21], and carcino-
genic PAHs against non-carcinogenic PAHs in HepG2
cells [22]. However, the number of publications using
PCA in toxicogenomics is still limited. We are now try-
ing to apply this type of analysis on selected key genes
to rodent liver gene expression profiles that have been
described previously (unpublished).
Additionally, the involvement of next-generation sequen-
cing (NGS) technology for the study of toxicogenomics is
now being introduced [23–25]. Jiang et al. reported that
NGS technologies, in comparison to microarray-based
technologies, may overcome the current limitations, and
are promising for the development of predictive models in
the near future [23]. Maslov et al. [24] suggested that the
NGS era is well underway; new methods have been devel-
oped to directly analyze genetic material in a genome-wide
manner with single nucleotide resolution. Moreover, there
is no dependency on any particular gene or cell line, and
the genetic material derived from any cell or tissue can be
analyzed. This makes NGS-based mutagenicity assays par-
ticularly suitable for use in genetic toxicology. As toxicology
continues to develop, we expect that testing methods will
continue to change in concert with increased knowledge
and understanding.
Conclusions
In the present review, we summarize our toxicoge-
nomics collaborative studies. We selected and quantified
by qPCR candidate marker genes to discriminate mouse
genotoxic hepatocarcinogens from non-genotoxic hepa-
tocarcinogens examined by DNA microarrays. We deter-
mined 30 key genes by dose responses in mouse liver
gene expression induced by DEN and ENU at 4 h and
28 days, and extracted key times between 4 and 48 h
from time-course studies during the acute phase induced
by chrysene. Finally, we successfully showed the disc-




somorpholine, quinoline, and urethane] from four
Fig. 4 The gene networks and pathways of 24 genes quantified in the present study. The network was constructed from the results of Ingenuity
Pathway Analysis, GeneSpring software and references from PubMed. The 15 red-colored genes indicated with an asterisk are genes that
significantly contributed to the discrimination of the genotoxic hepatocarcinogens from the non-genotoxic hepatocarcinogen and the
non-genotoxic non-hepatocarcinogen by PCA. Fig. 3 in [15]
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non-genotoxic hepatocarcinogens [1,4-dichloroben-
zene, dichlorodiphenyltrichloroethane, DEHP, and
furan] and in rat liver two genotoxic hepatocarcino-
gens [diethylnitrosamine and 2,6-dinitrotoluene] from
a non-genotoxic hepatocarcinogen [DEHP] and a non-
genotoxic and non-hepatocarcinogen [phenacetin]
determined by qPCR and PCA at 4 and 48 h after
administration of chemicals. The subsequent gene
pathway studies extracted the DNA damage response,
resulting from signal transduction by a p53-class me-
diator leading to the induction of apoptosis. These
studies suggest that application of PCA in the study of
toxicogenomics is useful to discriminate genotoxic
hepatocarcinogens from non-genotoxic hepatocarcino-
gens and/or non-hepatocarcinogens in rodent liver.
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